Trials / Conditions / Shock, Cardiogenic

Shock, Cardiogenic

28 registered clinical trials studyying Shock, Cardiogenic — 7 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Procizumab (PCZ; AK1967) in Critical Cardiovascular Care NCT06832722	4TEEN4 Pharmaceuticals GmbH	Phase 1 / Phase 2
Not Yet Recruiting	Ciprofol's Impact on Oxygenator Function in Extracorporeal Membrane Oxygenation (ECMO) Patients NCT06934811	First Affiliated Hospital of Wannan Medical College	Phase 4
Recruiting	Digital Out-of-hospital Management on Clinical Outcomes in Patients With Early Cardiogenic Shock NCT07085221	Renmin Hospital of Wuhan University	N/A
Enrolling By Invitation	Mobile Education and Telephone Monitoring for ICD Patients: Effects on Anxiety, Acceptance, and Self-Efficacy NCT06935526	Akdeniz University	N/A
Recruiting	ECMO LEft Ventricle UNloading Strategy NCT06766006	Maastricht University Medical Center	—
Recruiting	Hemodynamic Comparison of Peripheral and Central VA ECMO. NCT05669183	First Affiliated Hospital Xi'an Jiaotong University	—
Recruiting	CAPITAL DOREMI 2: Inotrope Versus Placebo Therapy for Cardiogenic Shock NCT05267886	Ottawa Heart Institute Research Corporation	Phase 4
Unknown	Impella in Cardiogenic Shock Registry NCT06007963	Universitaire Ziekenhuizen KU Leuven	—
Unknown	Validity of Cardiac Output Measurement Using Niccomo Device After Cardiac Surgery NCT04643509	University Hospital, Rouen	—
Unknown	Attenuation of Post-infarct LV Remodeling by Mechanical Unloading Using Impella-CP NCT04562272	Institute for Clinical and Experimental Medicine	N/A
Unknown	Postoperative Respiratory Abnormalities NCT04079829	Efficacy Care R&D Ltd	—
Unknown	Nitric Oxide in Venoarterial Extracorporeal Membrane Oxygenation (VA ECMO) NCT04224103	Filio Billia	—
Completed	Blood Management During ECMO for Cardiac Support NCT03714048	St Vincent's Hospital, Sydney	—
Completed	Clinical Validation of Algorithms for Mean Systemic Filling Pressure and Automated Cardiac Output NCT04202432	Catharina Ziekenhuis Eindhoven	—
Completed	Impact of Adrenoreceptor Expressions on Inflammatory Pattern in Refractory Cardiogenic Shock Under VA ECMO NCT03327493	Central Hospital, Nancy, France	N/A
Completed	Validation of Epworth Richmond's Echocardiography Education Focused Year NCT02961439	Epworth Healthcare	—
Unknown	Clinical Outcomes and Efficacy of Left Ventricular Assist Device for Korean Patients With Cardiogenic Shock NCT02985008	Jeong Hoon Yang	—
Completed	French Observatory on the Management of Cardiogenic Shock in 2016 NCT02703038	French Cardiology Society	—
Active Not Recruiting	GLP-1 and Hyperoxia for Organ Protection in Heart Surgery NCT02673931	Rigshospitalet, Denmark	N/A
Completed	Synchronized Cardiac Assist for Cardiogenic Shock NCT02697006	Xenios AG	—
Completed	Intraaortic Balloon Pump in Cardiogenic Shock II NCT00491036	University of Leipzig	Phase 4
Completed	Effects of Pyruvate in Patients With Cardiogenic Shock and Intra-aortic Balloon Counterpulsation NCT00604331	Herzzentrum Goettingen	Phase 2
Completed	Abciximab in Patients Undergoing Percutaneous Coronary Intervention for Cardiogenic Shock NCT00420030	Charles University, Czech Republic	Phase 4
Terminated	Comparison of Standard Treatment Versus Standard Treatment Plus Extracorporeal Life Support (ECLS) in Myocardi NCT00314847	University Hospital, Caen	Phase 4
Terminated	A Study of the Safety and Efficacy of Nitric Oxide Reduction in Patients With Cardiogenic Shock After a Heart NCT00112281	Arginox Pharmaceuticals	Phase 3
Completed	Australia and New Zealand Adult Extracorporeal Membrane Oxygenation (ECMO) Audit 2005 NCT00157144	Bayside Health	—
Completed	Efficacy Study of LV Assist Device to Treat Patients With Cardiogenic Shock (ISAR-SHOCK) NCT00417378	Deutsches Herzzentrum Muenchen	Phase 4
Completed	Shock Trial: Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. NCT00000552	Carelon Research	Phase 3